Pemetrexed (Alimta): clinical trials recruiting now
3
Recruiting trials
5
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 2
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer · Pemetrexed (Alimta) for Lung cancer | 3 |
| Advanced Non Small Cell Lung Cancer | 1 |
| MET Exon 14 Mutation | 1 |
| NSCLC (Advanced Non-small Cell Lung Cancer) | 1 |
| Pleural Mesotheliomas | 1 |
Recruiting trials involving Pemetrexed (Alimta)
- Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
- Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
- Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma
Common questions
How many recruiting trials involve Pemetrexed (Alimta)?
3 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.